Back to search

Belgium· BE-AMP-SAM167307-00

Omniscan 0.5 mmol/ml

A gadodiamide product containing gadodiamide, registered in Belgium by GE Healthcare. The same ATC class is registered in 7 of our 19 countries.

ATC V08CA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedOmniscan 0.5 mmol/mlATCV08CA03REGISTER NO.BE-AMP-SAM167307-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Gadodiamide is registered in 7 of 19 countries.

Countries holding a registration under ATC V08CA03 (gadodiamide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose

Gadodiamide · ATC V08CA03

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Germany
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Gadodiamide
Manufacturer
GE Healthcare
Country
Belgium (BE)
ATC code
V08CA03
ATC class
Gadodiamide
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    1182757
  • be_apb
    0743146

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

131 interactions on record for gadodiamide.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gadodiamide · interactions on record

131 records

  • 19 moderate
  • 112 info

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gadodiamide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gadodiamide products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Omniscan
  • Bulgaria · Омнискен
  • Cyprus · Omniscan
  • Germany · Omniscan
  • Estonia · Omniscan
  • United Kingdom (Northern Ireland) · Omniscan
  • Greece · Omniscan
  • Croatia · Omniscan
  • Hungary · Omniscan
  • Ireland · Omniscan
  • Iceland · Omniscan
  • Italy · Omniscan
  • Lithuania · Omniscan
  • Luxembourg · Omniscan
  • Latvia · Omniscan
  • Malta · Omniscan
  • Netherlands · Omniscan
  • Norway · Omniscan
  • Poland · Omniscan
  • Portugal · Omniscan
  • Romania · Omniscan
  • Sweden · Omniscan
  • Slovenia · Omniscan
  • Slovakia · Omniscan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d429c0d1-ea12-460c-bf60-c155505ef8e5
GET /v1/drugs/d429c0d1-ea12-460c-bf60-c155505ef8e5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "SUSPENDED",
  "name_en": "Omniscan 0.5 mmol/ml",
  "name_fr": "Omniscan 0.5 mmol/ml",
  "name_nl": "Omniscan 0.5 mmol/ml",
  "amp_code": "SAM167307-00",
  "strengths": [
    "287.0000",
    "287.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Gadodiamide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Gadodiamide",
  "authorisation_numbers": [
    "BE167307",
    "BE204321"
  ]
}

See everything about gadodiamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.